Clinical Trial Update: Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 pilot study evaluating sofosbuvir plus ribavirin with a fixed-dose HIV antiretroviral co-formulation (elvitegravir/cobicistat/emtricitabine/tenofovir) i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sovaldi (Sofosbuvir)
• Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir disoproxil fumarate)

Snippet

Sponsor: Saint Michael's Medical Center | Conditions: Hepatitis C Infection, HIV Infection | Phase 4 | Status: COMPLETED